<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02000349</url>
  </required_header>
  <id_info>
    <org_study_id>Reprogenetics-3.117</org_study_id>
    <nct_id>NCT02000349</nct_id>
  </id_info>
  <brief_title>Comparison of Frozen-thawed Embryo Transfers and Fresh Embryo Transfers With Whole Chromosome Analysis Using Next Generation Sequencing</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reprogenetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Reproductive Medicine Lab, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Reprogenetics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to perform a clinical randomized trial to evaluate the effect of a
      frozen-thawed embryo transfer and a fresh embryo transfer on pregnancy and implantation
      rates; with the added benefit of a blastocyst biopsy and whole chromosome analysis by Next
      Generation Sequencing (NGS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Fresh group: All embryos will be hatched on day 3. Patients will have hatching
           blastocysts (*) biopsied on day 5, analyzed by NGS, and will have one or two euploid
           embryo transferred on day 6, in the am. If more than two euploid blastocysts are
           available the one(s) to be transferred will be selected based on morphology (*). Any
           morulas developing to hatching blastocyst on day-6 will be also analyzed but vitrified
           for use in a future cycle.

        2. Frozen group: All embryos will be hatched on day 3. Patients will have hatching
           blastocysts (*) biopsied on day 5 or day 6, embryos will then be vitrified, analyzed by
           NGS, and will have one or two euploid embryo(s) thawed and transferred on a FET cycle,
           before noon. If more than two euploid blastocysts are available the one(s) to be
           transferred will be selected based on morphology (*).

      (*) Hatching blastocysts as described by Gardner and Schoolcraft (1999):
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>8 weeks after replacement</time_frame>
    <description>determining whether a frozen or a fresh embryo transfer will improve implantation rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of Mitochondrial DNA and implantation</measure>
    <time_frame>When a fetal heartbeat is detected (8 weeks after implantation)</time_frame>
    <description>The second aim of this study is to determine retrospectively if mt DNA content is linked to implantation potential and if that is measurable by NGS. NGS provides the additional advantage that it can measure mitochondrial DNA, which it's content, seems to be inversely correlated with implantation (Fragouli et al 2013, ASRM).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Frozen Embryo Transfer with PGD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All embryos will be hatched on day 3. Patients will have hatching blastocysts (*) biopsied on day 5 or day 6, embryos will then be vitrified, analyzed by NGS, and will have one or two euploid embryo(s) thawed and transferred on a FET cycle, before noon. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (*).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh Embryo Transfer with PGD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All embryos will be hatched on day 3. Patients will have hatching blastocysts (*) biopsied on day 5, analyzed by NGS, and will have one or two euploid embryo transferred on day 6, in the am. If more than two euploid blastocysts are available the one(s) to be transferred will be selected based on morphology (*). Any morulas developing to hatching blastocyst on day-6 will be also analyzed but vitrified for use in a future cycle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PGD</intervention_name>
    <description>PGD using Next generation sequencing</description>
    <arm_group_label>Frozen Embryo Transfer with PGD</arm_group_label>
    <arm_group_label>Fresh Embryo Transfer with PGD</arm_group_label>
    <other_name>PGD (Preimplantation Genetic Diagnosis)</other_name>
    <other_name>NGS (Next Generation Sequencing)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (pre-stimulation):

          -  Age up to 42 years

        Exclusion Criteria (pre-stimulation):

          -  MESA and TESE patients

          -  At least one partner carrier of a chromosomal abnormality

          -  Egg donor cycle (sperm donor is acceptable)

          -  Gender selection cycles

          -  Thaw cycles

          -  Any patient who cannot have a fresh embryo transfer

          -  FSH above 12 or AMH less than 1
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Santiago Munne, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Reprogenetics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reproductive Medicine Lab, LLC</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ata B, Kaplan B, Danzer H, Glassner M, Opsahl M, Tan SL, Munné S. Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. Reprod Biomed Online. 2012 Jun;24(6):614-20. doi: 10.1016/j.rbmo.2012.02.009. Epub 2012 Feb 25.</citation>
    <PMID>22503277</PMID>
  </reference>
  <reference>
    <citation>Cohen J, DeVane GW, Elsner CW, Kort HI, Massey JB, Norbury SE. Cryopreserved zygotes and embryos and endocrinologic factors in the replacement cycle. Fertil Steril. 1988 Jul;50(1):61-7.</citation>
    <PMID>3384119</PMID>
  </reference>
  <reference>
    <citation>Cohen J, Wells D, Munné S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2007 Mar;87(3):496-503. Epub 2006 Dec 4.</citation>
    <PMID>17141767</PMID>
  </reference>
  <reference>
    <citation>De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, Liebaers I, Van de Velde H. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod. 2009 Dec;24(12):2988-96. doi: 10.1093/humrep/dep251. Epub 2009 Sep 21.</citation>
    <PMID>19773223</PMID>
  </reference>
  <reference>
    <citation>Sagoskin AW, Levy MJ, Tucker MJ, Richter KS, Widra EA. Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial. Fertil Steril. 2007 Feb;87(2):283-7. Epub 2006 Nov 13.</citation>
    <PMID>17094975</PMID>
  </reference>
  <reference>
    <citation>Fragouli E, Spath K, Alfarawati S, Wells D (2013) Quantification of mitochondrial DNA predicts the implantation potential of chromosomally normal embryos. Fertil Steril, in press (ASRM abstract)</citation>
  </reference>
  <reference>
    <citation>Gardner DK and Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D. eds. Towards Reproductive Certainty: Fertility and Genetics Beyond 1999. Carnforth, Parthenon Publishin, 1999, 378-88</citation>
  </reference>
  <reference>
    <citation>Gutiérrez-Mateo C, Colls P, Sánchez-García J, Escudero T, Prates R, Ketterson K, Wells D, Munné S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011 Mar 1;95(3):953-8. doi: 10.1016/j.fertnstert.2010.09.010. Epub 2010 Oct 25.</citation>
    <PMID>20971462</PMID>
  </reference>
  <reference>
    <citation>Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA, Glassner M, Munné S. Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertil Steril. 2012 Sep;98(3):675-80. doi: 10.1016/j.fertnstert.2012.05.025. Epub 2012 Jun 7.</citation>
    <PMID>22683012</PMID>
  </reference>
  <reference>
    <citation>Munné S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010 Jul;94(2):408-30. doi: 10.1016/j.fertnstert.2009.02.091. Epub 2009 May 5. Review.</citation>
    <PMID>19409550</PMID>
  </reference>
  <reference>
    <citation>SART (2011): https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0</citation>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2013</study_first_submitted>
  <study_first_submitted_qc>November 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2013</study_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>next generation sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

